BIIB
Biogen Inc.
Stock
$222.82−3.06 (−1.35%)Close Oct 1, 2026
| Capital expenditures (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $182M | +32.0% | −18.4% | −13.3% |
| Capital expenditures (TTM) | $182M |
|---|---|
| YoY | +32.0% |
| 5-year CAGR | −18.4% |
| 10-year CAGR | −13.3% |
Capital expenditures
| Period | Capex | YoY |
|---|---|---|
| 2025 | $154M | +0.1% |
| 2024 | $154M | −44.5% |
| 2023 | $277M | +15.3% |
| 2022 | $240M | −6.9% |
| 2021 | $258M | −39.2% |
| 2020 | $425M | −17.4% |
| 2019 | $515M | −33.2% |
| 2018 | $771M | −11.2% |
| 2017 | $867M | +40.8% |
| 2016 | $616M | −4.2% |
| 2015 | $643M | +123.4% |
| 2014 | $288M | +16.8% |
| 2013 | $246M | −3.2% |
| 2012 | $255M | +22.4% |
| 2011 | $208M | +20.2% |
| 2010 | $173M | +4.5% |
| 2009 | $166M | −40.0% |
| 2008 | $276M | −2.9% |
| 2007 | $284M | — |